AP
Acurx Pharmaceuticals LLC
🇺🇸XNAS.ACXPUnited StatesHealthcare
$1.38USDup +0.02 (+1.47%)ClosedEnd of day7:41 AM
Price$1.38+0.02 (+1.47%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US00510M2035
- CUSIP
- 00510M104
Company
- Employees
- 4
- Headquarters
- Staten Island, United States
- Website
- https://www.acurxpharma.com
- CEO
- Mr. David P. Luci C.P.A., Esq., J.D.
Market
- Shares outstanding
- 4.3M
- Market cap
- $5.93M
Highlights
- Market cap
- $5.93M
- EPS LTM
- -$1.76
- P/E LTM
- -0.88
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$7.51M+24.93%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$6.18M+24.25%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.